SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017180
Filing Date
2023-05-03
Accepted
2023-05-03 16:11:25
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cere-20230331.htm   iXBRL 10-Q 3123672
2 EX-10.1 cere-ex10_1.htm EX-10 88235
3 EX-31.1 cere-ex31_1.htm EX-31 19011
4 EX-31.2 cere-ex31_2.htm EX-31 18997
5 EX-32.1 cere-ex32_1.htm EX-32 10814
6 EX-32.2 cere-ex32_2.htm EX-32 10820
7 GRAPHIC img33027544_0.jpg GRAPHIC 2072932
8 GRAPHIC img188018671_0.jpg GRAPHIC 37418
  Complete submission text file 0000950170-23-017180.txt   15976874

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cere-20230331.xsd EX-101.SCH 59493
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cere-20230331_pre.xml EX-101.PRE 388583
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cere-20230331_cal.xml EX-101.CAL 59093
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cere-20230331_def.xml EX-101.DEF 241193
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cere-20230331_lab.xml EX-101.LAB 501015
72 EXTRACTED XBRL INSTANCE DOCUMENT cere-20230331_htm.xml XML 2336257
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 23883833
SIC: 2834 Pharmaceutical Preparations